Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG00010 multiple ascending dose study in sciatica
NL-OMON35890Active, not recruiting
- Sponsor
- Biogen
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of artemin in Sciatica and lumbodynia (LBP) (4 arms), sponsored by Biogen. Primary endpoints: Number and proportion of subjects with adverse events, Type and severity of adverse events and 2 more. Started Jun 2011; status: active, not recruiting.
02
Drugs
artemin
03
Conditions
Sciaticalumbodynia (LBP)
Beyond the preview
Go deeper on NL-OMON35890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35890.